Key result
In a murine breast cancer model, voluntary exercise training moderated doxorubicin-induced cardiotoxicities by blunting the increase in left ventricle glucose uptake, preventing left ventricle atrophy, and improving ejection fraction.
Why the study?
The effects of exercise training on cardiac function and glucose metabolism during doxorubicin treatment in breast cancer models remained unclear.
Does voluntary exercise training ameliorate doxorubicin-induced cardiotoxicity in a murine breast cancer model?
Does voluntary exercise training ameliorate doxorubicin-induced cardiotoxicity in a murine breast cancer model?
Voluntary exercise training mitigates doxorubicin-induced cardiotoxicity, including LV atrophy and reduced ejection fraction, in a murine breast cancer model.
Answers are grounded in this paper and cite their sources.
Supports exercise to mitigate doxorubicin cardiotoxicity in murine models; hypothesis-generating for clinical translation.
INTRODUCTION: Doxorubicin is a chemotherapeutic drug used to treat various cancers. Exercise training (ET) can attenuate some cardiotoxic effects of doxorubicin (DOX) in tumor-free animals. However, the ET effects on cardiac function and glucose metabolism in DOX-treated breast cancer models remain unclear. OBJECTIVES: This study investigated ET-induced structural, functional, vascular, oxidative stress, and plausible glucose uptake alterations of the left ventricle (LV) in a murine breast cancer model during DOX treatment. METHODS: F]fluoro-2-deoxy-D-glucose positron emission tomography and echocardiography after two and four DOX-doses. The cardiac histology, oxidative stress, maximal metabolic enzyme activities, and mitochondrial respiration were analyzed. RESULTS: DOX increased LV glucose uptake (LVGU) and mitochondrial uncoupling and decreased running activity, LV-weight, and ejection fraction (EF). In DOX-treated group ET blunted the increase in LVGU, increased LV-weight and EF, and lowered LV lactate dehydrogenase activity. DOX-treated exercised mice did not differ from tumor-bearing group without DOX in LVGU or from the tumor-free ET-group in LV-weight or EF whereas unexercised DOX-treated group did. ET also increased LV citrate synthase activity in tumor-bearing animals. There was an inverse association between LVGU and EF and LV-weight. CONCLUSION: In a murine breast cancer model, voluntary ET moderated DOX-induced cardiotoxicities such as increased LVGU, LV-atrophy and decreased EF. This suggests that ET might benefit patients with cancer undergoing doxorubicin treatment by mitigating cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Uurasmaa et al. (2025) studied Doxorubicin-induced cardiotoxicity in breast cancer (n=74). Voluntary wheel-running exercise training vs. No exercise (locked wheels) was evaluated on Left ventricle glucose uptake, ejection fraction, and left ventricle mass. In a murine breast cancer model, voluntary exercise training moderated doxorubicin-induced cardiotoxicities by blunting the increase in left ventricle glucose uptake, preventing left ventricle atrophy, and improving ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: